Heterogeneity of anthracycline retention and response to efflux blockers in human tumors

A. Krishan

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Rapid cellular efflux of certain natural products used in cancer chemotherapy leads to reduced cytotoxicity and resistance. Multiple Drug Resistance (MDR) gene related glycoproteins are believed to act as the drug efflux pump. Several non-cancer therapy drugs (e.g., verapamil, phenothiazines) compete for the p-glycoprotein pump and thus can block efflux of a chemotherapeutic agent and overcome cellular resistance. Anthracyclines, such as adriamycin, are intrinsically fluorescent and thus their cellular retention can be determined by laser now cytometry. This method has been used to study heterogeneity in cellular retention of anthracyclines and response to efflux blockers in human tumor cells. These studies have led to generation of clinical protocols where laser now cytometry is used to monitor and overcome heterogeneity in drug retention of tumor cells from patients treated with a combination of adriamycin and efflux blockers.

Original languageEnglish
Pages (from-to)72-75
Number of pages4
JournalCytometry
Volume21
Issue number1
DOIs
StatePublished - Oct 10 1995
Externally publishedYes

Fingerprint

Anthracyclines
Doxorubicin
Glycoproteins
Lasers
Phenothiazines
Drug Therapy
Neoplasms
Multiple Drug Resistance
Clinical Protocols
Verapamil
Biological Products
Pharmaceutical Preparations
Genes

Keywords

  • Adriamycin
  • Anthracyclines
  • Efflux
  • MDR
  • Resistance

ASJC Scopus subject areas

  • Hematology
  • Cell Biology
  • Pathology and Forensic Medicine
  • Biophysics
  • Endocrinology

Cite this

Heterogeneity of anthracycline retention and response to efflux blockers in human tumors. / Krishan, A.

In: Cytometry, Vol. 21, No. 1, 10.10.1995, p. 72-75.

Research output: Contribution to journalArticle

@article{83a1acedcd354c6d887ceb2edaa12931,
title = "Heterogeneity of anthracycline retention and response to efflux blockers in human tumors",
abstract = "Rapid cellular efflux of certain natural products used in cancer chemotherapy leads to reduced cytotoxicity and resistance. Multiple Drug Resistance (MDR) gene related glycoproteins are believed to act as the drug efflux pump. Several non-cancer therapy drugs (e.g., verapamil, phenothiazines) compete for the p-glycoprotein pump and thus can block efflux of a chemotherapeutic agent and overcome cellular resistance. Anthracyclines, such as adriamycin, are intrinsically fluorescent and thus their cellular retention can be determined by laser now cytometry. This method has been used to study heterogeneity in cellular retention of anthracyclines and response to efflux blockers in human tumor cells. These studies have led to generation of clinical protocols where laser now cytometry is used to monitor and overcome heterogeneity in drug retention of tumor cells from patients treated with a combination of adriamycin and efflux blockers.",
keywords = "Adriamycin, Anthracyclines, Efflux, MDR, Resistance",
author = "A. Krishan",
year = "1995",
month = "10",
day = "10",
doi = "10.1002/cyto.990210114",
language = "English",
volume = "21",
pages = "72--75",
journal = "Cytometry Part B - Clinical Cytometry",
issn = "1552-4949",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Heterogeneity of anthracycline retention and response to efflux blockers in human tumors

AU - Krishan, A.

PY - 1995/10/10

Y1 - 1995/10/10

N2 - Rapid cellular efflux of certain natural products used in cancer chemotherapy leads to reduced cytotoxicity and resistance. Multiple Drug Resistance (MDR) gene related glycoproteins are believed to act as the drug efflux pump. Several non-cancer therapy drugs (e.g., verapamil, phenothiazines) compete for the p-glycoprotein pump and thus can block efflux of a chemotherapeutic agent and overcome cellular resistance. Anthracyclines, such as adriamycin, are intrinsically fluorescent and thus their cellular retention can be determined by laser now cytometry. This method has been used to study heterogeneity in cellular retention of anthracyclines and response to efflux blockers in human tumor cells. These studies have led to generation of clinical protocols where laser now cytometry is used to monitor and overcome heterogeneity in drug retention of tumor cells from patients treated with a combination of adriamycin and efflux blockers.

AB - Rapid cellular efflux of certain natural products used in cancer chemotherapy leads to reduced cytotoxicity and resistance. Multiple Drug Resistance (MDR) gene related glycoproteins are believed to act as the drug efflux pump. Several non-cancer therapy drugs (e.g., verapamil, phenothiazines) compete for the p-glycoprotein pump and thus can block efflux of a chemotherapeutic agent and overcome cellular resistance. Anthracyclines, such as adriamycin, are intrinsically fluorescent and thus their cellular retention can be determined by laser now cytometry. This method has been used to study heterogeneity in cellular retention of anthracyclines and response to efflux blockers in human tumor cells. These studies have led to generation of clinical protocols where laser now cytometry is used to monitor and overcome heterogeneity in drug retention of tumor cells from patients treated with a combination of adriamycin and efflux blockers.

KW - Adriamycin

KW - Anthracyclines

KW - Efflux

KW - MDR

KW - Resistance

UR - http://www.scopus.com/inward/record.url?scp=0029100327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029100327&partnerID=8YFLogxK

U2 - 10.1002/cyto.990210114

DO - 10.1002/cyto.990210114

M3 - Article

C2 - 8529475

AN - SCOPUS:0029100327

VL - 21

SP - 72

EP - 75

JO - Cytometry Part B - Clinical Cytometry

JF - Cytometry Part B - Clinical Cytometry

SN - 1552-4949

IS - 1

ER -